Arrowhead Pharmaceuticals Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants

Core Viewpoint - Arrowhead Pharmaceuticals, Inc. has announced the pricing of its concurrent public offerings, which include $625 million in convertible senior notes and 3,100,776 shares of common stock priced at $64.50 per share [1] Group 1: Public Offerings - The company is offering $625,000,000 aggregate principal amount of 0.00% convertible senior notes due in 2032 [1] - Additionally, the company is offering 3,100,776 shares of common stock at a public offering price of $64.50 per share [1] - For certain investors, pre-funded warrants are available at a public offering price of $64.499 per warrant, for up to 1,550 [1]